Brief: Simulations Plus Inc - U.S. FDA Renews Annual DILIsym Software Licenses For 2022
05/05/2022 13:38
May 5 (Reuters) - Simulations Plus Inc SLP.O :
* SIMULATIONS PLUS INC - U.S. FDA RENEWS ANNUAL DILISYM
SOFTWARE
LICENSES FOR 2022
Source text for Eikon: ID:nBw8rBZVva
Further company coverage: SLP.O
Recent news on Simulations Plus
See all newsBrief: Simulations Plus Altaris To Pay $26 Million Termination Fee To Co If Merger Agreement Terminated
NASDAQ RESUMED AT 09:55 AM
Brief: Simulations Plus To Be Acquired By Altaris For Approximately $375 Million
NASDAQ TRADE HALT HALT NEWS PENDING AT 08:55 AM
Simulations Plus Q2 results beat expectations but lowers annual profit forecast on tax rate jump